There is a 90 percent chance that people who have filed two or more autism-related insurance claims have an autism diagnosis, says a study published 5 June in Autism.

Males, but not females, with neurodevelopmental disorders such as autism are more likely to have deletions or duplications in the 16p13.11 chromosomal region than controls are, according to a study published 18 April in PLoS One.

Few studies of autism prevalence have been conducted in low- and middle-income countries. Freely available screening and diagnostic tools could help address this disparity.

Discrepancies in global wealth create hurdles for autism diagnosis, treatments and cross-cultural research. How can open-access tools fix the problem?

Autism researchers disagree on what genetic information or clinical services they should offer participants after a study ends.

Insulin-like growth factor 1, a drug approved for use in children with short stature, reverses neurological deficits in mice with an autism-linked mutation in the SHANK3 gene, according to a study published 27 April in Molecular Autism. 

Two new studies raise questions about one of the most frequently reported biological signatures of autism: a larger-than-normal head.

Screening the genome for small chromosomal abnormalities may identify potential genetic causes of autism or intellectual disability in 16 percent of children tested, according to a study published 24 May in the European Journal of Paediatric Neurology.

The number of autism research studies in the U.K. has doubled in the past decade, but the country still lags behind the U.S. in the amount of funding and the diversity of its projects, according to a report released today at the House of Lords.

A mild form of the fragile X mutation produces an unusual protein that may trigger fragile X-associated tremor/ataxia syndrome, a neurodegenerative disorder, according to a study published 8 May in Neuron.